drug

rozanolixizumab

Status: FDA approved Jun 2023 · BLA761286
Brand: Rystiggo

Relationships

Developed by UCB

Timeline

No published stories yet.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.